Germany
Japan
United Kingdom
China
USD 509.00
2 Weeks
Primary Antibodies
View as table Download
USD 509.00
2 Weeks
Carrier-free (BSA/glycerol-free) PIM2 mouse monoclonal antibody, clone OTI8G10 (formerly 8G10)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) PRKCE mouse monoclonal antibody, clone OTI2A12 (formerly 2A12)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) NRBP1 mouse monoclonal antibody, clone OTI5C3 (formerly 5C3)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
Active filters
Category
- Antibodies
Reactivities
- Rat
Applications
- IHC
Isotypes
- IgG2b
Families
- Protein Kinase
Brands
- TrueMAB
Filter by
Target Symbol
- MEK1 (70)
- MEK3 (54)
- HER2 (28)
- MADM (20)
- PKC EPSILON (20)
- PLK1 (20)
- LIM KINASE 1 (15)
- SAPK4 (15)
- CHK2 (10)
- MEK4 (10)
- PROTEIN KINASE D2 (10)
- STK39 (10)
- TYRO3 (10)
- B RAF (5)
- CDKL1 (5)
- CSNK1G1 (5)
- ERBB 4 (5)
- JAK2 (5)
- KIST (5)
- MAPK4 (5)
- MET (5)
- MTOR (5)
- PIM2 (5)
- PKC NU (5)
- PRPK (5)
- PTK9 (5)
- RET (5)
- STK3 (5)
- TIF1 GAMMA (5)
- TLK2 (5)
- BTK (4)
- FGFR2 (3)
- MAP2K3 (1)
Antibody Hosts
Clonalities
Conjugates
Carrier-free
Knockout (KO) Validation
Pathways
- Fc epsilon RI signaling pathway (174)
- MAPK signaling pathway (163)
- GnRH signaling pathway (150)
- Toll-like receptor signaling pathway (150)
- ErbB signaling pathway (123)
- Pathways in cancer (121)
- Prostate cancer (111)
- Progesterone-mediated oocyte maturation (110)
- Focal adhesion (108)
- Fc gamma R-mediated phagocytosis (105)
- Bladder cancer (103)
- Endometrial cancer (103)
- Non-small cell lung cancer (103)
- Pancreatic cancer (103)
- Vascular smooth muscle contraction (95)
- Regulation of actin cytoskeleton (93)
- Neurotrophin signaling pathway (90)
- Oocyte meiosis (90)
- Acute myeloid leukemia (85)
- T cell receptor signaling pathway (85)
- VEGF signaling pathway (85)
- Chemokine signaling pathway (80)
- Colorectal cancer (80)
- Glioma (80)
- Insulin signaling pathway (80)
- Melanoma (80)
- Renal cell carcinoma (80)
- Thyroid cancer (80)
- Chronic myeloid leukemia (75)
- Long-term depression (75)
- Long-term potentiation (75)
- Natural killer cell mediated cytotoxicity (75)
- B cell receptor signaling pathway (74)
- Amyotrophic lateral sclerosis (ALS) (70)
- Dorso-ventral axis formation (70)
- Gap junction (70)
- Melanogenesis (70)
- Prion diseases (70)
- Adherens junction (33)
- Calcium signaling pathway (33)
- Cell cycle (30)
- Epithelial cell signaling in Helicobacter pylori infection (30)
- Type II diabetes mellitus (25)
- Axon guidance (20)
- Tight junction (20)
- Endocytosis (18)
- Leukocyte transendothelial migration (15)
- NOD-like receptor signaling pathway (15)
- RIG-I-like receptor signaling pathway (15)
- Adipocytokine signaling pathway (10)
- mTOR signaling pathway (10)
- p53 signaling pathway (10)
- Cytokine-cytokine receptor interaction (5)
- Hedgehog signaling pathway (5)
- Jak-STAT signaling pathway (5)
- Primary immunodeficiency (4)